Singletrack X

SRG Advisors, LLC is a reputable accounting firm located in Hackensack, NJ, serving businesses in various industries and fields. With a team of experienced accountants, they offer expert tax planning, book balancing, and other accounting services to help businesses operate more efficiently and confidently. They specialize in providing real estate accounting services, catering to the unique needs and guidelines of real estate businesses in Hackensack and the surrounding communities. With a focus on quality and accuracy, SRG Advisors, LLC takes pride in their internal structure that promotes the review and revision of business tax returns and tax planning. Their high level of examination ensures that tax liabilities are not excessive or inaccurate, providing businesses with tax and accounting services of the highest caliber. With years of experience and a deep understanding of the real estate industry, realtors, property owners, and other companies in the field can trust SRG Advisors, LLC to provide them with the highest level of assistance.Generated from the website

Maxnet Technologies, based in Hackensack, NJ, is a specialized IT solutions provider with two decades of experience in Business Intelligence, Enterprise Data Warehousing, and Robotic Process Automation. The company focuses on delivering innovative, cost-effective solutions tailored to the unique needs of various industries, including retail, healthcare, and manufacturing. With a global presence including development centers in Pune, India, and Qatar, Maxnet technologies empowers businesses through advanced analytics and AI-driven solutions. Their commitment to customer satisfaction, proven by a 98% satisfaction rate, positions them as a leader in navigating complexity and simplifying IT challenges for clients around the world. Generated from the website

Champions Oncology is an American technology company that develops mouse avatars. Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies, and monoclonal antibodies to identify potential therapeutic options for cancer patients.